ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134754 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134754; 2) Community: the network communities that were significantly associated with the response to NSC 134754; 3) Molecule: the relationships between components within communities and NSC 134754; 4) MDR: the compounds that were significantly associated with the NSC 134754.

NSC Compound Enrichment Correlation
NSC 363812 Tetraplatin 0.0222343516878695 0.35363187
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0222343516878695 0.3451561
NSC 373980 Null 0.0222343516878695 0.43481722
NSC 38643 Lenamycin 0.0222343516878695 0.18001766
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0222343516878695 0.46181825
NSC 58239 A 80021F34 0.0222343516878695 0.44405291
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0222343516878695 0.3807946
NSC 628915 3-(2-N,N-diethylaminoethylamino)-1,2,4-benzotriazine 1,4-dioxide. Hemihydrate 0.0222343516878695 0.28748954
NSC 630511 1,4-Benzoquinone-2-methoxy-5-dimethylaminomethyl- 6-(10-heptadecenyl)-(Z)-, hydrochloride 0.0222343516878695 0.44040235
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.0222343516878695 0.55106335
Total:193  Current:118    [First] [Prev] [Next] [Last]